203 related articles for article (PubMed ID: 11834639)
21. Relationship between sensitivity to dyspnea and fluctuating peak expiratory flow rate in the absence of asthma symptoms.
Kamiya K; Sugiyama K; Toda M; Soda S; Ikeda N; Fukushima F; Hirata H; Fukushima Y; Fukuda T
Asia Pac Allergy; 2012 Jan; 2(1):49-58. PubMed ID: 22348207
[TBL] [Abstract][Full Text] [Related]
22. Case-control study of salmeterol and near-fatal attacks of asthma.
Williams C; Crossland L; Finnerty J; Crane J; Holgate S; Pearce N; Beasley R
Thorax; 1998 Jan; 53(1):7-13. PubMed ID: 9577515
[TBL] [Abstract][Full Text] [Related]
23. Variability in asthma: symptom perception, care, and outcomes.
Lougheed MD
Can J Physiol Pharmacol; 2007 Jan; 85(1):149-54. PubMed ID: 17487254
[TBL] [Abstract][Full Text] [Related]
24. Does self-monitoring by means of symptom diaries improve asthma control in children?
Arga M; Sahbaz H; Bakirtas A; Turktas I; Demirsoy MS
J Asthma; 2014 Apr; 51(3):299-305. PubMed ID: 24274828
[TBL] [Abstract][Full Text] [Related]
25. Reality and understanding of asthma control.
Beharry S; Gidla D; Maharaj A; Bisram S; Sakhamuri S; Seemungal TA; Pinto Pereira LM
Chron Respir Dis; 2015 Nov; 12(4):340-6. PubMed ID: 26272498
[TBL] [Abstract][Full Text] [Related]
26. Changes of Peak Expiratory Flow Rate in Adult Asthmatic Patient.
Nasreen S; Nessa A; Islam F; Khanam A; Sultana R; Rahman R; Hossain M
Mymensingh Med J; 2018 Apr; 27(2):245-250. PubMed ID: 29769485
[TBL] [Abstract][Full Text] [Related]
27. A randomized, controlled study to evaluate the role of an in-home asthma disease management program provided by respiratory therapists in improving outcomes and reducing the cost of care.
Shelledy DC; Legrand TS; Gardner DD; Peters JI
J Asthma; 2009 Mar; 46(2):194-201. PubMed ID: 19253130
[TBL] [Abstract][Full Text] [Related]
28. [Management according to the Global Initiative for Asthma guidelines of patients with near-fatal asthma reduces morbidity and mortality].
Rodríguez-Trigo G; Plaza V; Picado C; Sanchis J
Arch Bronconeumol; 2008 Apr; 44(4):192-6. PubMed ID: 18423180
[TBL] [Abstract][Full Text] [Related]
29. National surveillance for asthma--United States, 1980-2004.
Moorman JE; Rudd RA; Johnson CA; King M; Minor P; Bailey C; Scalia MR; Akinbami LJ;
MMWR Surveill Summ; 2007 Oct; 56(8):1-54. PubMed ID: 17947969
[TBL] [Abstract][Full Text] [Related]
30. Regular inhaled beta agonist in asthma: effects on exacerbations and lung function.
Taylor DR; Sears MR; Herbison GP; Flannery EM; Print CG; Lake DC; Yates DM; Lucas MK; Li Q
Thorax; 1993 Feb; 48(2):134-8. PubMed ID: 8493626
[TBL] [Abstract][Full Text] [Related]
31. Prospective multicenter study of relapse following treatment for acute asthma among adults presenting to the emergency department. MARC investigators. Multicenter Asthma Research Collaboration.
Emerman CL; Woodruff PG; Cydulka RK; Gibbs MA; Pollack CV; Camargo CA
Chest; 1999 Apr; 115(4):919-27. PubMed ID: 10208187
[TBL] [Abstract][Full Text] [Related]
32. Long-term smoking increases the need for acute care among asthma patients: a case control study.
Kauppi P; Kupiainen H; Lindqvist A; Haahtela T; Laitinen T
BMC Pulm Med; 2014 Jul; 14():119. PubMed ID: 25030656
[TBL] [Abstract][Full Text] [Related]
33. Determinants of near fatality in acute severe asthma.
Kallenbach JM; Frankel AH; Lapinsky SE; Thornton AS; Blott JA; Smith C; Feldman C; Zwi S
Am J Med; 1993 Sep; 95(3):265-72. PubMed ID: 8368225
[TBL] [Abstract][Full Text] [Related]
34. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
[TBL] [Abstract][Full Text] [Related]
35. Near fatal asthma attacks: the reliability of descriptive information collected from close acquaintances.
Campbell DA; McLennan G; Coates JR; Frith PA; Gluyas PA; Latimer KM; Martin AJ; Roder DM; Ruffin RE; Scarce D
Thorax; 1993 Nov; 48(11):1099-104. PubMed ID: 8296251
[TBL] [Abstract][Full Text] [Related]
36. Demographic characteristics of patients experiencing near-fatal and fatal asthma: results of a regional survey of 400 asthma specialists [see comment].
Hannaway PJ
Ann Allergy Asthma Immunol; 2000 Jun; 84(6):587-93. PubMed ID: 10875486
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for near-fatal asthma. A case-control study in hospitalized patients with asthma.
Turner MO; Noertjojo K; Vedal S; Bai T; Crump S; Fitzgerald JM
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1804-9. PubMed ID: 9620909
[TBL] [Abstract][Full Text] [Related]
38. Comparison of asthmatic patients admitted to hospital from health districts experiencing high and low asthma mortality rates.
Littlejohns P; Hollowell J; Hayward P; Prance S
Postgrad Med J; 1994 Feb; 70(820):92-9. PubMed ID: 8170898
[TBL] [Abstract][Full Text] [Related]
39. The effect of nebulized magnesium sulfate in the treatment of moderate to severe asthma attacks: a randomized clinical trial.
Hossein S; Pegah A; Davood F; Said A; Babak M; Mani M; Mahdi R; Peyman H
Am J Emerg Med; 2016 May; 34(5):883-6. PubMed ID: 26964827
[TBL] [Abstract][Full Text] [Related]
40. A randomized clinical trial of magnesium sulphate as a vehicle for nebulized salbutamol in the treatment of moderate to severe asthma attacks.
Kokturk N; Turktas H; Kara P; Mullaoglu S; Yilmaz F; Karamercan A
Pulm Pharmacol Ther; 2005; 18(6):416-21. PubMed ID: 15953743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
